B. Doerken

发表

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region

M. Schmidt‐Hieber, A. Nogai, I. Blau, 2015, BMC Cancer.

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

R. Greil, H. Eich, V. Diehl, 2005 .

Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study

H. Oettle, H. Riess, D. Arnold, 2010, BMC Cancer.

Mediastinal Clear Cell Lymphoma-A Distinct Entity of B-Cell Derived Lymphoma as Shown by Immunotyping and Analysis of Gene Rearrangements.

W. Knauf, P. Moeller, B. Doerken, 1991, Leukemia & lymphoma.

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

R. Greil, H. Eich, V. Diehl, 2005 .

HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)

R. Greil, V. Diehl, L. Kanz, 2005 .

Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study.

J. Schulz-Menger, M. Friedrich, R. Wassmuth, 2001, American heart journal.

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

R. Greil, H. Eich, V. Diehl, 2004 .

Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation

C. Lutz, I. Tamm, M. Seibold, 2008, Transplant infectious disease : an official journal of the Transplantation Society.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Peter Neuhaus, Jan Langrehr, Karsten Ridwelski, 2007, JAMA.

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region

A. Nogai, I. Blau, A. Pezzutto, 2015, BMC Cancer.

I{kappa}B-{zeta} controls the constitutive NF-{kappa}B target gene network and survival of ABC DLBCL

G. Lenz, M. Hummel, C. Scheidereit, 2013 .

Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression

P. Schlattmann, P. Reinke, N. Babel, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Notch inhibition blocks multiple myeloma cell-induced osteoclast activation

R. Preissner, O. Sezer, R. Schwarzer, 2008, Leukemia.

Monotherapy with the anti-CD20 antibody rituximab (ritux) in patients with post-transplant lympho-proliferative disease (PTLD). Results of a multicentre phase II study.

U. Jaeger, M. Hallek, P. Reinke, 2002 .

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

H. Oettle, I. Schmidt-Wolf, K. Ridwelski, 2007 .

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

R. Greil, H. Eich, V. Diehl, 2004 .